FX.co ★ Cullinan Therapeutics Appoints Fenton As CFO

On Monday, it was revealed that Mary Kay Fenton will be taking on the role of Chief Financial Officer at Cullinan Therapeutics, Inc. (CGEM), starting from April 29. Boasting an impressive thirty years of experience in finance and operations within the biotech industry, Fenton has contributed her expertise across numerous companies, each specializing in different areas of disease, including immunology. Prior to her new role at Cullinan Therapeutics, Fenton proved herself in various roles, including both Interim Chief Executive Officer and Chief Financial Officer, at Talaris Therapeutics, Inc.